Basingstoke-based Shire agrees to AbbVie deal

Shire's Basingstoke base at Hampshire International Business Park

Shire's Basingstoke base at Hampshire International Business Park

First published in Hampshire Business by

THE board of Basingstoke-based Shire plc agreed to merge with American drugs company AbbVie Inc.

The deal values Shire at around £32 billion, with the board recommending the most recent bid to its investors, of £53.20 per share.

Commenting on the merger, Richard Gonzalez, chairman of the board and chief executive officer of AbbVie said: "By combining AbbVie and Shire, we’re creating a unique, diversified biopharmaceutical company.

“The combined company would benefit from a best-in-class product development platform, a stronger pipeline and more enhanced R&D capabilities.”


Comments are closed on this article.

Send us your news, pictures and videos

Most read stories

Local Info

Enter your postcode, town or place name

About cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies. Find out more about the cookies we use.

I agree